Research programme: molecular machines therapeutics - MOMA Therapeutics
Alternative Names: Molecular machines inhibitors - MOMALatest Information Update: 28 May 2024
At a glance
- Originator MOMA Therapeutics
- Class Antineoplastics; Small molecules
- Mechanism of Action Enzyme modulators; Molecular motor protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer